Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc    MYL   US6285301072

MYLAN INC (MYL)

52
Delayed Quote. Delayed Nasdaq - 08/20 04:00:01 pm
48.59 USD   +3.30%
2h ago Mylan Launches Generic Xeloda® Tablets
4h agoDJADR Shares End Mixed; Luxottica Shares Active
1d ago MYLAN : Launches Generic Precedex™ Injection - Another Key Product Ap..
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Mylan Inc. : Mylan Launches First Generic Version of Doryx® 150 mg

04/30/2012 | 02:20pm US/Eastern
Recommend:
0

PITTSBURGH, April 30, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150 mg, following a favorable decision by the U.S. District Court for the District of New Jersey in a patent infringement lawsuit brought by Warner Chilcott. The Court held, after trial, that Mylan's product does not infringe the subject patent. Mylan is shipping product immediately.

Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150 mg is the generic version of Mayne Pharma's Doryx(®) 150 mg product (marketed by Warner Chilcott), and is a tetracycline-class antimicrobial.

Doxycycline Hyclate DR Tablets, 150 mg, had U.S. sales of approximately $264.1 million for the 12 months ending Dec. 31, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.

SOURCE Mylan Inc.

Recommend :
0
React to this article
Latest news on MYLAN INC
2h ago Mylan Launches Generic Xeloda® Tablets
4h agoDJADR Shares End Mixed; Luxottica Shares Active
1d ago MYLAN : Launches Generic Precedex™ Injection - Another Key Product Approva..
1d ago MYLAN : Launches Generic Precedex(TM) Injection - Another Key Product Approval
08/11 MYLAN : Launches Generic Xeloda® Tablets
08/08 Delphi to contest pressure to file U.S. taxes despite UK tax base
08/08 MYLAN : Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With ..
08/07DJADR Shares End Lower; Statoil Shares Trade Actively
08/07DJU.S. Stock Slide; Dow Industrials Fall to Lowest Since April
08/07 MYLAN : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
Dynamic quotes  
ON
| OFF